Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJLEN.L Regulatory News (JLEN)

  • There is currently no data for JLEN

Acquisition

1 Aug 2022 07:01

RNS Number : 3477U
JLEN Environmental Assets Group Ltd
01 August 2022
 

1 August 2022

 

JLEN Environmental Assets Group Limited

("JLEN" or the "Company")

 

Investment in a controlled environment aquaculture project

JLEN, the listed environmental infrastructure fund, is pleased to announce that it has reached financial close on a minority equity investment in a controlled environment aquaculture project. 

The equity investment will be made alongside other Foresight funds, as well as the developer and operator of the facility, Hima Seafood AS. JLEN's total investment is expected to be up to approximately £40m over the next three to four years.

The project consists of a land-based aquaculture facility to be built in Rjukan, Norway, and will use established recirculating aquaculture system ("RAS") technology. It is expected that partial operations will commence in 2024 with full operations expected in 2025, following which, the facility is forecasted to produce approximately 8,000 tonnes of trout annually. This will be sold to European and international salmonid markets via an offtake agreement with an established Norwegian seafood distribution company with global reach.

Driven by a growing global population and an expanding middle class, the world faces an increasing demand for quality protein amid limited resources of usable land and water. Recent data shows that 34.8%1 of global animal protein production comes from fish and seafood sources and the fish and seafood market grew between 4% - 8% annually in the ten-year period to 20191. 

Global demand for animal protein is projected to double by 20502. Fish, including salmonids such as salmon and trout, is considered one of the most efficient sources of high-quality animal protein due to the rate at which it converts feed into edible mass, its high protein retention and high rate of edible meat per kilogram, as well as various nutritional benefits. Land-based aquaculture, such as the RAS based facility to be built in Rjukan, can provide a range of benefits compared with alternative methods of aquaculture such as improved fish mortality rates, less local environmental degradation and a lower use of antibiotics and other chemicals to control disease and parasites.

 

Richard Ramsay, Senior Independent Director of JLEN, said:

 

"We are pleased to make our first investment into land-based aquaculture, contributing to the sustainable supply of trout to meet rising consumer demand. We consider that this investment will deliver environmental benefits to the food system and offer a product to suit today's consumer needs."

1) Source: United Nations FAO, FAOSTAT Statistical Database

2) Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532560/#B2-foods-06-00053

 

For further information and enquiries, please contact:

 

Foresight Group

Chris Tanner

Chris Holmes

 

+44 (0)20 3667 8100

Winterflood Investment Trusts

Neil Langford

Chris Mills

 

+44 (0)20 3100 0000

SEC Newgate (For media enquiries)

Elisabeth Cowell

+44 (0)20 3757 6882

jlen@secnewgate.co.uk

 

Sanne Fund Services (Guernsey) Limited

Matt Falla

Gemma Woods

+44 (0)14 8175 5530

 

About JLEN

JLEN's investment policy is to invest in a diversified portfolio of Environmental Infrastructure. Environmental Infrastructure is defined by the Company as infrastructure assets, projects and asset-backed businesses that utilise natural or waste resources or support more environmentally friendly approaches to economic activity, support the transition to a low carbon economy or which mitigate the effects of climate change. Such investments will typically feature one or more of the following characteristics:

- long-term, predictable cash flows, which may be wholly or partially inflation-linked cash flows;

- long-term contracts or stable and well-proven regulatory and legal frameworks; or

- well-established technologies, and demonstrable operational performance.

JLEN's aim is to provide investors with a sustainable, progressive dividend per share, paid quarterly and to preserve the capital value of the portfolio over the long term on a real basis. The target dividend for the year to 31 March 2023 is 7.14 pence per share1. The dividend is payable quarterly.

Further details of the Company can be found on its website www.jlen.com

LEI: 213800JWJN54TFBMBI68

(1) These are targets only and not profit forecasts. There can be no assurance that these targets will be met or that the Company will make any distributions at all.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQRBMFTMTAJBIT
Date   Source Headline
1st May 20197:00 amRNSNotice of Results
15th Mar 201910:37 amRNSUpdate research from QuotedData
13th Mar 20194:56 pmRNSJohn Laing Pension Trust - Result of Share Sale
8th Mar 20197:00 amRNSJohn Laing Pension Trust - Proposed Sale of Shares
7th Mar 20197:00 amRNSNet Asset Value and Dividend
19th Dec 20187:00 amRNSAcquisition
30th Nov 20184:19 pmRNSTotal Voting Rights
22nd Nov 20187:00 amRNSHalf-year Results, Dividend Declaration
9th Nov 20187:00 amRNSNotice of Results
24th Oct 20185:11 pmRNSDirector/PDMR Shareholding
24th Oct 20183:59 pmRNSHolding(s) in Company
24th Oct 20183:47 pmRNSHolding(s) in Company
19th Oct 201811:55 amRNSResult of Issue
13th Sep 201811:44 amRNSUpdate research from QuotedData
12th Sep 20187:00 amRNSProposed Placing, Offer for Subscription
3rd Sep 20185:59 pmRNSHolding(s) in Company
23rd Aug 20181:04 pmRNSHolding(s) in Company
16th Aug 20187:01 amRNSNet Asset Value and Dividend Declaration
16th Aug 20187:00 amRNSAcquisition
15th Aug 20183:58 pmRNSResult of AGM
9th Jul 20187:00 amRNSAcquisition
26th Jun 201811:56 amRNSNotice of AGM
22nd Jun 20182:59 pmRNSPublication of Suppl.Prospcts
22nd Jun 20188:15 amRNSAcquisition
14th Jun 20187:00 amRNSAnnual Financial Report
31st May 20187:00 amRNSNet Asset Value and Dividend Declaration
23rd May 20187:00 amRNSCapital Markets Event
13th Apr 20184:29 pmRNSDirector Declaration
29th Mar 20185:48 pmRNSTotal Voting Rights
14th Mar 20185:57 pmRNSHolding(s) in Company
7th Mar 20187:00 amRNSResult of Initial Placing
6th Mar 20181:32 pmRNSUpdate research from QuotedData
2nd Mar 201811:09 amRNSResult of EGM
23rd Feb 201812:11 pmRNSPublication of Prospectus
21st Feb 20188:18 amRNSProposed Initial Placing
12th Feb 20187:00 amRNSPublication of Circular & Notice of EGM
2nd Feb 20187:00 amRNSAcquisition
23rd Jan 20187:00 amRNSNet Asset Value and Dividend Declaration
12th Dec 20177:00 amRNSAcquisition
6th Dec 201711:50 amRNSHolding(s) in Company
22nd Nov 20177:00 amRNSHalf-year Results, Dividend Declaration
6th Nov 20177:00 amRNSInvestment Adviser
8th Sep 20177:55 amRNSInitiation research from QuotedData
29th Aug 20177:00 amRNSAcquisition
17th Aug 20177:00 amRNSNet Asset Value and Dividend
16th Aug 20171:11 pmRNSResults of AGM
31st Jul 20177:00 amRNSTotal Voting Rights
14th Jul 20179:52 amRNSHolding(s) in Company
13th Jul 20173:16 pmRNSHolding(s) in Company
12th Jul 201710:00 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.